Atlas Trials

A Dose-ranging Pharmacokinetics and Safety Study of GWP42003-P in Children With Dravet Syndrome (GWPCARE1)

Clinical trial NCT02091206 · COMPLETED

Trial details

NCT number
NCT02091206
Sponsor
Jazz Pharmaceuticals
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
EpilepsyDravet Syndrome
Start date
2014-10-22
Primary completion
2015-03-09
Enrollment
34

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.